Local Biotech Company is Improving Clinical Care for Animals

Local Biotech Company is Improving Clinical Care for Animals

PetVet Dx celebrated recent expansion and future plans at a community event Friday

NEW ORLEANS (March 31, 2023) Local biotech company PetVet Dx hosted a community event last Friday to celebrate their recent expansion in the New Orleans BioInnovation Center (NOBIC.) The program capped off with a donation to both the New Orleans Police Department Canine Unit and Audubon Zoo.

PetVet Dx is a therapeutic management company specializing in Infectious Disease and Cancer molecular diagnostic testing to improve clinical care in all species of animals. Its revolutionary technology provides an effective and efficient testing product for veterinarians, farmers, and pet owners. 

“As a company, we felt it was important to thank the community we are a part of,” said David Kutrucz, President of PetVetDX. “Support the NOPD Canine Unit and Audubon Zoo just made sense. Not only are we proud to make a monetary donation, we also donated our diagnostic services.”

PetVet Dx offers the most comprehensive infectious disease tests and identification of antibiotic resistance genes on the market.  PetVet Dx is the only laboratory in the nation utilizing and offering the most advanced, CDC-recommended technology to produce the most comprehensive reporting within 24 hours with an unequaled accuracy rate of 99.8%.

In addition, PetVet Dx’s testing solution provides you with pharmacological antibiotic medication reporting to help veterinarians, pet owners, and farmers better understand identified infections and their treatment.

For more information, please visit here.

###

PetVet Dx: PetVet Dx is a therapeutic management company specializing in targeted PCR molecular diagnostics to improve clinical care in all species of animals. Our revolutionary molecular technology provides a firm foundation for diagnostics in animal health services for veterinarians, farmers, and pet owners. PetVet Dx believes that the only diagnostic test that should be performed is one that will improve an animal’s overall outcome.

The New Orleans BioInnovation Center Welcomes Program Director

 

The New Orleans BioInnovation Center Welcomes Program Director

Muieen Cader to coordinate capital access & experiential learning programming

NEW ORLEANS (Feb. 9, 2023) — The New Orleans BioInnovation Center (NOBIC), a private, not-for-profit business incubator, supporting entrepreneurship and dedicated to the development of bioscience innovation throughout Louisiana, announced today the addition of Muieen Cader as program director.

“Muieen brings an array of experience in early-stage investing, with an emphasis in program development and capital deployment within underserved communities,” said NOBIC Executive Director Kris Khalil. “We’re very
excited for him to join our growing team. He will undoubtedly make an immediate impact on the biotech industry in New Orleans.”

maueenCader has a strong background in venture capital, having served as a Senior Associate with Garden District Ventures, where he was responsible for investment memo preparation, due diligence, LP outreach, and adding
value for prospective portfolio companies. He is actively involved in the venture capital community through his contributions to OpenVC.app and his Medium blog focused on venture capital and diversity, where he has
been recognized as a “Top writer.”

One of Cader’s first initiatives will be to build a new experiential learning programming for local graduate students and supporting early-stage companies through their milestone journeys, with a focus on supporting
biotech companies to obtain much-needed risk capital.

Outside of the office, Cader is a passionate sailor, having sailed with some of the best teams in the world.
For more information about Cader and NOBIC, visit neworleansbio.com.

###

About New Orleans BioInnovation Center :
The New Orleans BioInnovation Center (“NOBIC”) is a nonprofit business incubator focused on advancing life science entrepreneurship and technology commercialization in Louisiana. The mission of NOBIC is to create a successful biotech ecosystem by providing emerging companies with customized commercialization services, premier facilities and a comprehensive support network. Through relationships with research institutions, economic development organizations and industry stakeholders, NOBIC helps its clients de-risk novel technologies, attract funding and improve global health outcomes. For more information, visit neworleansbio.com/.